Ottimo Pharma
PrivateLast Round
Series A
Dec 19, 2024
Total Funding Raised
$140M
Company Overview
Ottimo Pharma is a biotechnology company that develops cancer therapies for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ottimo Pharma Comps
Public and private peers based on sector, stage, and business model.
Ottimo Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 19, 2024 |
Ottimo Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series A |
| Avoro Capital | Series A |
| OrbiMed | Series A |
| Decheng Capital | Series A |
| Invus Opportunities | Series A |
| J.P. Morgan Life Sciences Private Capital | Series A |
| RTW Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2025
Partnered with Asimov for cell line development.
- Jun 23, 2025
Contract manufacturing agreement signed with LOTTE BIOLOGICS for antibody therapeutics.
Ottimo Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ottimo Pharma's valuation, stock price, and market status.
